ID: ALA2089161

Max Phase: Preclinical

Molecular Formula: C23H31N7O3

Molecular Weight: 453.55

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1cnc[nH]1)C(N)=O

Standard InChI:  InChI=1S/C23H31N7O3/c1-13(2)7-20(23(33)29-19(21(25)31)9-15-11-26-12-28-15)30-22(32)17(24)8-14-10-27-18-6-4-3-5-16(14)18/h3-6,10-13,17,19-20,27H,7-9,24H2,1-2H3,(H2,25,31)(H,26,28)(H,29,33)(H,30,32)/t17-,19-,20-/m0/s1

Standard InChI Key:  SEOJXUBBJSRPDC-IHPCNDPISA-N

Associated Targets(non-human)

Snake venom metalloproteinase Bap1 31 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 453.55Molecular Weight (Monoisotopic): 453.2488AlogP: 0.50#Rotatable Bonds: 11
Polar Surface Area: 171.78Molecular Species: NEUTRALHBA: 5HBD: 6
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 8#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.12CX Basic pKa: 7.66CX LogP: -0.22CX LogD: -0.73
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.25Np Likeness Score: -0.08

References

1. Villalta-Romero F, Gortat A, Herrera AE, Arguedas R, Quesada J, de Melo RL, Calvete JJ, Montero M, Murillo R, Rucavado A, Gutiérrez JM, Pérez-Payá E..  (2012)  Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design.,  (7): [PMID:24900507] [10.1021/ml300068r]

Source